In Silico and In Vivo Evaluation of SARS-CoV-2 Predicted Epitopes-Based Candidate Vaccine
SARS-CoV-2 예측 에피토프 기반 후보 백신의 In Silico 및 In Vivo 평가
Article
[키워드] acute respiratory syndrome
additive effect
antibody
antigenic
B and T-cell
B cell epitope
B cell epitopes
binding epitope
candidate
causative agent
caused
Combination
combinations
conserved
coronavirus
coronavirus 2
coronavirus disease
COVID-19 infections
demonstrated
epitope
Epitopes
female
groups
health authorities
high mortality rate
Human
identify
immunize
immunized mice
immunoinformatics
in silico
MHC-I
MHC-II
mice
pandemic
peptide
peptides
prediction
Protein
provide
public health authorities
raised
reactive
Receptor binding domain
respiratory
SARS-CoV-2
SARS-CoV-2 sequence
selected
Severe acute respiratory syndrome
severe acute respiratory syndrome Coronavirus
severe acute respiratory syndrome coronavirus 2
T-cell
T-cells
therapeutic intervention
therapy
vaccination
Vaccine
vaccine candidate
were used
[DOI] 10.3390/molecules26206182 PMC 바로가기 [Article Type] Article
[DOI] 10.3390/molecules26206182 PMC 바로가기 [Article Type] Article